Good stocks for the rest of the year?
I really like Oracle right now
What about you guys?
Keywords
I really like Oracle right now
What about you guys?
| +102 | KISSED MY VP… HELP!!! | 16 | 1d |
| +27 | How expensive is SF? | 14 | 4d |
| +15 | Give me all your ideas | 2 | 14h |
| +9 | Morning or evening for gym time? | 12 | 10h |
| +9 | Your experiences with digital twins in industry? | 0 | 5h |
| +7 | Does SpeedX China Accelerator Really Work | 1 | 9h |
| 0 | What is a tool that you wish you had and would use every day? | 3 | 3d |
| 0 | ib with coc clan leader background? | 2 | 1d |
Career Resources
I think it's time to buy some puts at these all time highs. Limited risk if the bull run continues, but cash in anytime we get taper talk.
Go to Finviz.com, look at the stock screener, look at EVERY chart for the Biotech stocks. There are tons that are money printers. http://finviz.com/screener.ashx?v=111&f=ind_biotechnology&o=-change
I don't venture much into stocks under the broader "Healthcare" sector, but dang, STXS was on fire today. And of course, I have to be broke. http://finviz.com/screener.ashx?v=111&f=sec_healthcare&o=-change
Seriously though, look at STXS's chart for today, tell me you couldn't scalp 10% off it even starting at/after 10am.
STXS is big, same for ADHD, SRPT (been liking this since early this year in the mid 20s), the list goes on.
Broad market? Screw that. You can always find a biotech trending up regardless of the cyclicality of the market, and if you're concerned about a market crash, just get some puts on SPDR.
I am personally a fan of Qualcomm. I bought it when it was 3% down YTD and have enjoyed a small 8% run since. It's under-performed the S&P this year and is a great play on the shift to to 3G and 4G with its LTE leadership. It's definitely not a stock that's gonna pop any time soon, (it's a 115 billion in market cap after all) but I think the moat is great, and can deliver both revenue growth and earnings over the next few years consistently. Great core large cap holding. Feel free to disagree
Near term catalysts - September iPhone 5S/low end iPhone release, increase in share buyback/capital allocation come analyst day in November.
SQM. It got hit hard with the Potash cartel breakup but this stock is much more then that. It is so diversified its management can divert resources away from their Potash division into Iodine or Lithium production
Voluptates non et molestiae est eum ut possimus. In rem maxime impedit sed.
Nisi reprehenderit qui eos laudantium. Dolores esse in id optio fugit. Molestiae atque deserunt voluptas quo. Et voluptatem voluptatem sint unde. Perspiciatis excepturi nemo aut dolorem temporibus ipsam deserunt.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...